Journal of Interventional Cardiology / 2021 / Article / Tab 1 / Research Article
High-Dose Atorvastatin Raises Threshold of Contrast-Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention: A Randomized Controlled Study Table 1 The baseline demographic, clinical, echocardiographic, and laboratory data of the studied population.
Parameter Age in years (mean ± SD) 58.8 ± 7.8 Sex, males (%) 94 (47) Smokers (%) 39 (19.5) HTN (%) 77 (38.5) Previous PCI (%) 8 (4) Duration of DM in years (mean ± SD) 7 ± 3.9 Insulin therapy (%) 95 (47.5) Heart failure (%) 44 (22) Body mass index (mean ± SD) 27.2 ± 3.3 Heart rate in beats/min. (mean ± SD) 84.5 ± 14.5 Systolic blood pressure in mmHg (mean ± SD) 132.9 ± 18.8 Diastolic blood pressure in mmHg (mean ± SD) 83.9 ± 10.4 Segmental wall motion abnormalities (%) 68 (34) EF (%) (mean ± SD) 59.3 ± 9.8 Volume of contrast in ml (mean ± SD) 121.4 ± 48.3 Time of X-ray exposure in min. (mean ± SD) 12 ± 5.5 Coronary procedure PCI with one stent 133 (66.5) PCI with two stents 53 (26.5) PCI with more than two stents 14 (7) TIMI flow TIMI I 2 (1) TIMI II 9 (4.5) TIMI III 189 (94.5) Baseline serum creatinine in umol/L (mean ± SD) 119.1 ± 16.8 Follow-up serum creatinine in umol/L (mean ± SD) 136.1 ± 25.6 Hemoglobin in mg/dL (mean ± SD) 12.3 ± 1.6 CIN (%) 24 (12)